Trichet V - Search Results

1

Plasma membrane reorganization links acid sphingomyelinase/ceramide to p38 MAPK pathways in endothelial cells apoptosis.

Niaudet C, Bonnaud S, Guillonneau M, Gouard S, Gaugler MH, Dutoit S, Ripoche N, Dubois N, Trichet V, Corre I, Paris F. Niaudet C, et al. Among authors: trichet v. Cell Signal. 2017 May;33:10-21. doi: 10.1016/j.cellsig.2017.02.001. Epub 2017 Feb 6. Cell Signal. 2017. PMID: 28179144

2

The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.

Corre I, Verrecchia F, Crenn V, Redini F, Trichet V. Corre I, et al. Among authors: trichet v. Cells. 2020 Apr 15;9(4):976. doi: 10.3390/cells9040976. Cells. 2020. PMID: 32326444 Free PMC article. Review.

3

Deciphering Tumor Niches: Lessons From Solid and Hematological Malignancies.

Mancini SJC, Balabanian K, Corre I, Gavard J, Lazennec G, Le Bousse-Kerdilès MC, Louache F, Maguer-Satta V, Mazure NM, Mechta-Grigoriou F, Peyron JF, Trichet V, Herault O. Mancini SJC, et al. Among authors: trichet v. Front Immunol. 2021 Nov 10;12:766275. doi: 10.3389/fimmu.2021.766275. eCollection 2021. Front Immunol. 2021. PMID: 34858421 Free PMC article. Review.

4

Mcl-1(128-350) fragment induces apoptosis through direct interaction with Bax.

Ménoret E, Gomez-Bougie P, Surget S, Trichet V, Oliver L, Pellat-Deceunynck C, Amiot M. Ménoret E, et al. Among authors: trichet v. FEBS Lett. 2010 Feb 5;584(3):487-92. doi: 10.1016/j.febslet.2009.11.094. Epub 2009 Dec 4. FEBS Lett. 2010. PMID: 19968986 Free article.

5

Farnesyl diphosphate synthase is involved in the resistance to zoledronic acid of osteosarcoma cells.

Ory B, Moriceau G, Trichet V, Blanchard F, Berreur M, Rédini F, Rogers M, Heymann D. Ory B, et al. Among authors: trichet v. J Cell Mol Med. 2008 Jun;12(3):928-41. doi: 10.1111/j.1582-4934.2008.00141.x. J Cell Mol Med. 2008. PMID: 18494934 Free PMC article.

6

Proteases and bone remodelling.

Georges S, Ruiz Velasco C, Trichet V, Fortun Y, Heymann D, Padrines M. Georges S, et al. Among authors: trichet v. Cytokine Growth Factor Rev. 2009 Feb;20(1):29-41. doi: 10.1016/j.cytogfr.2008.11.005. Epub 2008 Nov 28. Cytokine Growth Factor Rev. 2009. PMID: 19041277 Review.

7

Safety concern between autologous fat graft, mesenchymal stem cell and osteosarcoma recurrence.

Perrot P, Rousseau J, Bouffaut AL, Rédini F, Cassagnau E, Deschaseaux F, Heymann MF, Heymann D, Duteille F, Trichet V, Gouin F. Perrot P, et al. Among authors: trichet v. PLoS One. 2010 Jun 8;5(6):e10999. doi: 10.1371/journal.pone.0010999. PLoS One. 2010. PMID: 20544017 Free PMC article.

8

Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.

Le Nail LR, Brennan M, Rosset P, Deschaseaux F, Piloquet P, Pichon O, Le Caignec C, Crenn V, Layrolle P, Hérault O, De Pinieux G, Trichet V. Le Nail LR, et al. Among authors: trichet v. Int J Mol Sci. 2018 Mar 1;19(3):707. doi: 10.3390/ijms19030707. Int J Mol Sci. 2018. PMID: 29494553 Free PMC article.

9

Advantages of bioluminescence imaging to follow siRNA or chemotherapeutic treatments in osteosarcoma preclinical models.

Rousseau J, Escriou V, Perrot P, Picarda G, Charrier C, Scherman D, Heymann D, Rédini F, Trichet V. Rousseau J, et al. Among authors: trichet v. Cancer Gene Ther. 2010 Jun;17(6):387-97. doi: 10.1038/cgt.2009.89. Epub 2010 Jan 15. Cancer Gene Ther. 2010. PMID: 20075983

10

Recent advances in the management of osteosarcoma and forthcoming therapeutic strategies.

Lamoureux F, Trichet V, Chipoy C, Blanchard F, Gouin F, Redini F. Lamoureux F, et al. Among authors: trichet v. Expert Rev Anticancer Ther. 2007 Feb;7(2):169-81. doi: 10.1586/14737140.7.2.169. Expert Rev Anticancer Ther. 2007. PMID: 17288528 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page